Epic Sciences raises $52M Series E round to advance liquid biopsy diagnostics
The San Diego-based firm plans to integrate its "No Cell Left Behind" platform with electronic medical records and big data analytics.
The San Diego-based firm plans to integrate its "No Cell Left Behind" platform with electronic medical records and big data analytics.